CRIXIVAN (STAT Rx USA LLC)


Welcome to the PulseAid listing for the CRIXIVAN drug offered from STAT Rx USA LLC. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: STAT Rx USA LLC
NON-PROPRIETARY NAME: INDINAVIR SULFATE
SUBSTANCE NAME: INDINAVIR SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-03-13
END MARKETING DATE: 0000-00-00


CRIXIVAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCRIXIVAN from STAT Rx USA LLC
LABELER NAME: STAT Rx USA LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 1996-03-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16590-064_ab81071b-e065-49bc-9eee-5ad4c42b8d29
PRODUCT NDC: 16590-064
APPLICATION NUMBER: NDA020685

Other INDINAVIR SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalCRIXIVAN
Merck Sharp & Dohme Corp.CRIXIVAN
Rebel Distributors CorpCRIXIVAN
STAT Rx USA LLCCRIXIVAN
State of Florida DOH Central PharmacyCRIXIVAN